Related Experiment Videos
A convenient microscale colorimetric method for terminal galactose on immunoglobulins
1Analytical Chemistry, Genentech Inc., 1 DNA Way, South San Francisco, California, 94080, USA. sraju@gene.com
Biochemical and Biophysical Research Communications
|July 16, 1999
Summary
A novel method quantifies terminal galactose residues in immunoglobulins using enzyme digestion and a modified ferricyanide assay. This approach ensures accurate measurement of galactose content in therapeutic antibodies like recombinant IgG.
Area of Science:
- Biochemistry
- Analytical Chemistry
- Glycobiology
Background:
- Accurate quantification of terminal galactose residues in immunoglobulins is crucial for characterizing glycoprotein structure and function.
- Existing methods may lack sensitivity or stability for precise determination of these critical glycans.
Purpose of the Study:
- To develop and validate a novel, sensitive, and stable method for the quantitative determination of terminal galactose (Gal) residues in immunoglobulins.
- To optimize conditions for exoglycosidase digestion and improve the ferricyanide colorimetric assay for Gal quantification.
Main Methods:
- Combined exoglycosidase digestion using Diplococcus pneumoniae beta-D-galactosidase with a modified ferricyanide colorimetric assay.
- Modified the ferricyanide assay by increasing sulfuric acid and sodium dodecyl sulfate (SDS) concentrations to enhance chromophore stability and solubility.
- Separated released Gal from immunoglobulins and enzyme via heat denaturation or ethanol precipitation prior to colorimetric measurement.
Main Results:
- The modified method demonstrated a linear range of approximately 11 to 111 microM Gal with a typical assay variation of about 5%.
- Successfully quantified terminal Gal content in a recombinant chimeric monoclonal antibody (anti-CD20, rIgG) produced in Chinese hamster ovary (CHO) cells.
- The method was utilized to optimize digestion parameters (pH, time, temperature, enzyme concentration) for maximal Gal release from rIgG.
Conclusions:
- A robust and reliable method for quantifying terminal galactose residues in immunoglobulins has been established.
- The developed assay is suitable for assessing batch-to-batch consistency and optimizing production processes for glycoprotein therapeutics.
- This technique advances the analytical capabilities for characterizing immunoglobulin glycosylation patterns.